Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates
- PMID: 20845448
- PMCID: PMC3761878
- DOI: 10.1002/jps.22180
Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates
Abstract
Bacterial infections caused by Shigella flexneri, Salmonella typhimurium, and Burkholderia pseudomallei are currently difficult to prevent due to the lack of a licensed vaccine. Here we present formulation and immunogenicity studies for the three type III secretion system (TTSS) needle proteins MxiH(Δ5), PrgI(Δ5), and BsaL(Δ5) (each truncated by five residues at its C terminus) as potential candidates for vaccine development. These antigens are found to be thermally stabilized by the presence of carbohydrates and polyols. Additionally, all adsorb readily to aluminum hydroxide apparently through a combination of hydrogen bonds and/or Van der Waals forces. The interaction of these proteins with the aluminum-based adjuvant changes with time resulting in varying degrees of irreversible binding. Peptide maps of desorbed protein, however, suggest that chemical changes are not responsible for this irreversible association. The ability of MxiH(Δ5) and PrgI(Δ5) to elicit strong humoral immune responses was tested in a murine model. When administered intramuscularly as monomers, the needle components exhibited dose dependent immunogenic behavior. The polymerized version of MxiH was exceptionally immunogenic even at low doses. The responses of both monomeric and polymerized forms were boosted by adsorption to an aluminum salt adjuvant.
© 2010 Wiley-Liss, Inc. and the American Pharmacists Association
Figures
), PrgI Δ5 (
) and BsaL Δ5 (
) at 0.2 mg/mL in isotonic 10 mM Histidine buffer at pH 6.0.
) and PrgI Δ5 (
).
) and absence (-) of 10% Sucrose and 5% Dextrose.
), Alhydrogel Control (
), M1/M-His/P1 (
), M10/M-Al/P10 (
), M50/N-His/P50 (
). N-Al/P-Soln (
).References
-
- Shigella. 2009 [cited 2009 February 19]; Available from: http://www.who.int/vaccine_research/diseases/shigella/en/
-
- World Health Organiation Drug-Resistant Salmonella. 2005 [cited 2009 February 19]; Available from: http://www.who.int/mediacentre/factsheets/fs139/en/print.html.
-
- Salmonella Saintpaul Outbreak. 2008 [cited 2009 February 19]; Available from: http://www.fda.gov/oc/opacom/hottopics/tomatoes.html.
-
- Peanut Product Recalls: Salmonella Typhimurium. 2008 [cited 2009 February 19]; Available from: http://www.fda.gov/oc/opacom/hottopics/Salmonellatyph.html.
-
- National Center for Zoonotic V-B, and Enteric Diseases (ZVED). Melioidosis. 2008 March 27 2008 [cited 2009 February 20]; Available from: http://www.cdc.gov/nczved/dfbmd/disease_listing/melioidosis_gi.html.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
